Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
4257 | 1818 | 44.3 | 86% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
501 | 3 | SYSTEMIC SCLEROSIS//SCLERODERMA//IDIOPATHIC PULMONARY FIBROSIS | 22108 |
884 | 2 | SYSTEMIC SCLEROSIS//SCLERODERMA//RAYNAUDS PHENOMENON | 11430 |
4257 | 1 | SYSTEMIC SCLEROSIS//SCLERODERMA//TIGHT SKIN MOUSE | 1818 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | SYSTEMIC SCLEROSIS | authKW | 1649343 | 31% | 17% | 571 |
2 | SCLERODERMA | authKW | 627789 | 15% | 14% | 268 |
3 | TIGHT SKIN MOUSE | authKW | 204724 | 1% | 76% | 16 |
4 | REFERRAL SYST AUTOIMMUNE DIS | address | 186004 | 1% | 46% | 24 |
5 | EXPT RHEUMATOL | address | 162509 | 3% | 16% | 62 |
6 | RHEUMATOL CLIN IMMUNOGENET | address | 141659 | 2% | 25% | 34 |
7 | INRA 1152 | address | 131656 | 1% | 56% | 14 |
8 | RHEUMATOLOGY | WoSSC | 131162 | 49% | 1% | 884 |
9 | SERV RHUMATOL A | address | 99548 | 1% | 23% | 26 |
10 | RHEUMATOL CONNECT TISSUE DIS | address | 84978 | 1% | 19% | 27 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Rheumatology | 131162 | 49% | 1% | 884 |
2 | Dermatology | 5841 | 14% | 0% | 254 |
3 | Immunology | 1720 | 16% | 0% | 294 |
4 | Pathology | 440 | 5% | 0% | 92 |
5 | Medicine, Research & Experimental | 158 | 5% | 0% | 85 |
6 | Allergy | 84 | 1% | 0% | 22 |
7 | Cell Biology | 82 | 6% | 0% | 102 |
8 | Medicine, General & Internal | 29 | 4% | 0% | 67 |
9 | Medical Laboratory Technology | 8 | 1% | 0% | 11 |
10 | Biochemistry & Molecular Biology | 6 | 7% | 0% | 125 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | REFERRAL SYST AUTOIMMUNE DIS | 186004 | 1% | 46% | 24 |
2 | EXPT RHEUMATOL | 162509 | 3% | 16% | 62 |
3 | RHEUMATOL CLIN IMMUNOGENET | 141659 | 2% | 25% | 34 |
4 | INRA 1152 | 131656 | 1% | 56% | 14 |
5 | SERV RHUMATOL A | 99548 | 1% | 23% | 26 |
6 | RHEUMATOL CONNECT TISSUE DIS | 84978 | 1% | 19% | 27 |
7 | RHEUMATOL A | 80475 | 1% | 18% | 26 |
8 | CIC3 | 80012 | 0% | 53% | 9 |
9 | DERMATOL PLAST SURG | 76992 | 2% | 13% | 35 |
10 | RHEUMATOL | 65993 | 22% | 1% | 397 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ARTHRITIS AND RHEUMATISM | 74328 | 12% | 2% | 213 |
2 | ANNALS OF THE RHEUMATIC DISEASES | 26690 | 7% | 1% | 119 |
3 | ARTHRITIS RESEARCH & THERAPY | 25879 | 4% | 2% | 71 |
4 | CURRENT OPINION IN RHEUMATOLOGY | 24220 | 3% | 3% | 47 |
5 | ARTHRITIS & RHEUMATOLOGY | 18207 | 2% | 3% | 33 |
6 | CURRENT RHEUMATOLOGY REPORTS | 17290 | 1% | 5% | 22 |
7 | RHEUMATOLOGY | 15535 | 4% | 1% | 66 |
8 | JOURNAL OF RHEUMATOLOGY | 9658 | 5% | 1% | 86 |
9 | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 9516 | 3% | 1% | 56 |
10 | JOURNAL OF INVESTIGATIVE DERMATOLOGY | 8878 | 4% | 1% | 75 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SYSTEMIC SCLEROSIS | 1649343 | 31% | 17% | 571 | Search SYSTEMIC+SCLEROSIS | Search SYSTEMIC+SCLEROSIS |
2 | SCLERODERMA | 627789 | 15% | 14% | 268 | Search SCLERODERMA | Search SCLERODERMA |
3 | TIGHT SKIN MOUSE | 204724 | 1% | 76% | 16 | Search TIGHT+SKIN+MOUSE | Search TIGHT+SKIN+MOUSE |
4 | FIBROSIS | 73264 | 11% | 2% | 194 | Search FIBROSIS | Search FIBROSIS |
5 | DERMAL FIBROSIS | 71649 | 0% | 53% | 8 | Search DERMAL+FIBROSIS | Search DERMAL+FIBROSIS |
6 | SYSTEMIC SCLEROSIS SSC | 47242 | 1% | 26% | 11 | Search SYSTEMIC+SCLEROSIS+SSC | Search SYSTEMIC+SCLEROSIS+SSC |
7 | FUNCTIONAL AUTOANTIBODIES | 37786 | 0% | 75% | 3 | Search FUNCTIONAL+AUTOANTIBODIES | Search FUNCTIONAL+AUTOANTIBODIES |
8 | RENAL VASCULAR DAMAGE | 37786 | 0% | 75% | 3 | Search RENAL+VASCULAR+DAMAGE | Search RENAL+VASCULAR+DAMAGE |
9 | FLI1 | 34972 | 1% | 21% | 10 | Search FLI1 | Search FLI1 |
10 | BLEOMYCIN INDUCED FIBROSIS | 33589 | 0% | 100% | 2 | Search BLEOMYCIN+INDUCED+FIBROSIS | Search BLEOMYCIN+INDUCED+FIBROSIS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | PATTANAIK, D , BROWN, M , POSTLETHWAITEL, BC , POSTLETHWAITE, AE , (2015) PATHOGENESIS OF SYSTEMIC SCLEROSIS.FRONTIERS IN IMMUNOLOGY. VOL. 6. ISSUE . P. - | 160 | 38% | 20 |
2 | MORIN, F , KAVIAN, N , BATTEUX, F , (2015) ANIMAL MODELS OF SYSTEMIC SCLEROSIS.CURRENT PHARMACEUTICAL DESIGN. VOL. 21. ISSUE 18. P. 2365 -2379 | 106 | 68% | 2 |
3 | SALAZAR, G , MAYES, MD , (2015) GENETICS, EPIGENETICS, AND GENOMICS OF SYSTEMIC SCLEROSIS.RHEUMATIC DISEASE CLINICS OF NORTH AMERICA. VOL. 41. ISSUE 3. P. 345 -+ | 79 | 82% | 6 |
4 | GU, YS , KONG, J , CHEEMA, GS , KEEN, CL , WICK, G , GERSHWIN, ME , (2008) THE IMMUNOBIOLOGY OF SYSTEMIC SCLEROSIS.SEMINARS IN ARTHRITIS AND RHEUMATISM. VOL. 38. ISSUE 2. P. 132 -160 | 136 | 54% | 71 |
5 | HASEGAWA, M , TAKEHARA, K , (2012) POTENTIAL IMMUNOLOGIC TARGETS FOR TREATING FIBROSIS IN SYSTEMIC SCLEROSIS: A REVIEW FOCUSED ON LEUKOCYTES AND CYTOKINES.SEMINARS IN ARTHRITIS AND RHEUMATISM. VOL. 42. ISSUE 3. P. 281-296 | 114 | 63% | 11 |
6 | VARGA, J , ABRAHAM, D , (2007) SYSTEMIC SCLEROSIS: A PROTOTYPIC MULTISYSTEM FIBROTIC DISORDER.JOURNAL OF CLINICAL INVESTIGATION. VOL. 117. ISSUE 3. P. 557 -567 | 70 | 64% | 473 |
7 | ASANO, Y , (2016) RECENT ADVANCES IN ANIMAL MODELS OF SYSTEMIC SCLEROSIS.JOURNAL OF DERMATOLOGY. VOL. 43. ISSUE 1. P. 19 -28 | 74 | 73% | 1 |
8 | KATSUMOTO, TR , WHITFIELD, ML , CONNOLLY, MK , (2011) THE PATHOGENESIS OF SYSTEMIC SCLEROSIS.ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6. VOL. 6. ISSUE . P. 509 -537 | 80 | 61% | 83 |
9 | YAMAMOTO, T , (2010) ANIMAL MODEL OF SYSTEMIC SCLEROSIS.JOURNAL OF DERMATOLOGY. VOL. 37. ISSUE 1. P. 26 -41 | 87 | 66% | 22 |
10 | BROEN, JCA , RADSTAKE, TRDJ , ROSSATO, M , (2014) THE ROLE OF GENETICS AND EPIGENETICS IN THE PATHOGENESIS OF SYSTEMIC SCLEROSIS.NATURE REVIEWS RHEUMATOLOGY. VOL. 10. ISSUE 11. P. 671 -681 | 63 | 71% | 22 |
Classes with closest relation at Level 1 |